During the past decade, VZW Emmaus conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "VZW Emmaus" are "Atrial Fibrillation (AF)" (1 trials) and "Refractory and/or Unexplained Chronic Cough" (1 trials). Many other conditions were trialed in "VZW Emmaus" in a lesser frequency.

Most popular intervention types in "VZW Emmaus" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials), "BAY1817080" (1 trials), "BAY2433334" (1 trials) and "BAY2433334 matching placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "VZW Emmaus" are 2 trials for "All" genders.

Currently, there are NaN active trials in "VZW Emmaus". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in VZW Emmaus, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in VZW Emmaus, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".